Methylphenidate: Supply issue
There has been a worldwide shortage of methylphenidate.
On this page
10 November 2026 | Methylphenidate available
All brands and all strengths of methylphenidate are available. There are significant stockholdings in the country.
We are not currently anticipating future issues with the supply of funded brands in New Zealand.
There has been a global supply issue
Pharmac worked closely with suppliers and clinicians to manage a global issue affecting methylphenidate. Methylphenidate is used to treat attention deficit hyperactivity (ADHD) and narcolepsy.
Rising demand for methylphenidate coupled with overseas manufacturing issues led to long-term problems with supply of the medicine. Other countries, such as Australia and the United Kingdom, also experienced issues.
Pharmac funds multiple brands
To ensure people can continue to access methylphenidate, Pharmac has funded a range of immediate release and longer-acting versions of methylphenidate.
To help manage costs for the health system, some brands should be tried first (first-line). If those aren't effective people can try the second-line brands. To access these medicines, a prescriber needs to apply for a special authority.
|
Medicine |
Brand(s) |
Special Authority |
|---|---|---|
|
Methylphenidate (first-line brands) |
Ritalin (IR), Rubifen (IR), Rubifen SR, Rubifen LA, Methylphenidate ER – Teva, Methylphenidate Sandoz XR |
|
|
Methylphenidate (second-line brands) |
Concerta, Ritalin LA |
Different brands will work differently in your body
There are differences between how each of the longer acting brands work in your body. These differences will affect everyone in a different way. If you experience any changes, please talk to the person who prescribed your medicine
Prescribing health care professionals
BPACnz's advice on psychostimulant prescribing for ADHD. It includes a section on switching regimens when a preferred brand is not available.
Who to contact
If you take methylphenidate, talk with your doctor, nurse, or pharmacist if you have any questions about methylphenidate.
If you have questions about the funding of methylphenidate, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)
Pharmac is a government agency. We do not sell medicines or related products.